β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation

FASEB Journal

Volumn 28, Issue 8, 2014, Pages 3446-3455

  Boutin, Alisa ^a   Eliseeva, Elena ^a   Gershengorn, Marvin C ^a   Neumann, Susanne ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Bone; Osteopontin; Phosphokinases; Signaling; TSH receptor

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PROTEIN KINASE B; THYROTROPIN; THYROTROPIN RECEPTOR;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

BONE; OSTEOPONTIN; PHOSPHOKINASES; SIGNALING; TSH RECEPTOR;

ARRESTINS; BONE NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOPONTIN; OSTEOSARCOMA; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, THYROTROPIN; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THYROTROPIN;

EID: 84905230931     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-251124     Document Type: Article

References (36)

1. Davies, T. F., Ando, T., Lin, R. Y., Tomer, Y., and Latif, R. (2005) Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J. Clin. Invest. 115, 1972-1983 (Pubitemid 41134132)
2. Greenspan, S. L., and Greenspan, F. S. (1999) The effect of thyroid hormone on skeletal integrity. Ann. Intern. Med. 130, 750-758 (Pubitemid 29211514)
3. Rivkees, S. A., Bode, H. H., and Crawford, J. D. (1988) Longterm growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N. Engl. J. Med. 318, 599-602 (Pubitemid 18083591)
4. Abe, E., Marians, R. C., Yu, W., Wu, X. B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., Davies, T. F., and Zaidi, M. (2003) TSH is a negative regulator of skeletal remodeling. Cell 115, 151-162 (Pubitemid 37329579)
5. Wojcicka, A., Bassett, J. H., and Williams, G. R. (2013) Mechanisms of action of thyroid hormones in the skeleton. Biochim. Biophys. Acta 1830, 3979-3986
6. Sun, L., Vukicevic, S., Baliram, R., Yang, G., Sendak, R., McPherson, J., Zhu, L. L., Iqbal, J., Latif, R., Natrajan, A., Arabi, A., Yamoah, K., Moonga, B. S., Gabet, Y., Davies, T. F., Bab, I., Abe, E., Sampath, K., and Zaidi, M. (2008) Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc. Natl. Acad. Sci. U.S.A. 105, 4289-4294 (Pubitemid 351754373)
7. Baliram, R., Latif, R., Berkowitz, J., Frid, S., Colaianni, G., Sun, L., Zaidi, M., and Davies, T. F. (2011) Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures. Proc. Natl. Acad. Sci. U.S.A. 108, 16277-16282
8. Dewire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510
9. Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., and Lefkowitz, R. J. (2003) Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 100, 10782-10787 (Pubitemid 37140105)
10. Ren, X. R., Reiter, E., Ahn, S., Kim, J., Chen, W., and Lefkowitz, R. J. (2005) Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl. Acad. Sci. U.S.A. 102, 1448-1453 (Pubitemid 40209190)
11. Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., and Lefkowitz, R. J. (2006) beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281, 1261-1273
12. Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., and Lefkowitz, R. J. (2006) Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J. Biol. Chem. 281, 10856-10864 (Pubitemid 43855508)
13. Kuo, F. T., Lu, T. L., and Fu, H. W. (2006) Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1. Cell. Signal. 18, 1914-1923
14. Latif, R., Morshed, S. A., Zaidi, M., and Davies, T. F. (2009) The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol. Metab. Clin. N. Am. 38, 319-341
15. Iacovelli, L., Capobianco, L., Salvatore, L., Sallese, M., D'Ancona, G. M., and De Blasi, A. (2001) Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol. Pharmacol. 60, 924-933 (Pubitemid 33027427)
16. Pomerance, M., Abdullah, H. B., Kamerji, S., Correze, C., and Blondeau, J. P. (2000) Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade: involvement of protein kinase A, rac1, and reactive oxygen species. J. Biol. Chem. 275, 40539-40546 (Pubitemid 32064691)
17. Turcu, A. F., Kumar, S., Neumann, S., Coenen, M., Iyer, S., Chiriboga, P., Gershengorn, M. C., and Bahn, R. S. (2013) A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy. J. Clin. Endocrinol. Metab. 98, 2153-2159
18. Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., and Luttrell, L. M. (2009) A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci. Transl. Med. 1, 1ra1
19. Bisello, A., Chorev, M., Rosenblatt, M., Monticelli, L., Mierke, D. F., and Ferrari, S. L. (2002) Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J. Biol. Chem. 277, 38524-38530 (Pubitemid 35154711)
20. Ferrari, S. L., Pierroz, D. D., Glatt, V., Goddard, D. S., Bianchi, E. N., Lin, F. T., Manen, D., and Bouxsein, M. L. (2005) Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Endocrinology 146, 1854-1862 (Pubitemid 40396895)
21. Salvatori, L., Caporuscio, F., Coroniti, G., Starace, G., Frati, L., Russo, M. A., and Petrangeli, E. (2009) Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. J. Cell. Physiol. 220, 35-44
22. Neumann, S., Kleinau, G., Costanzi, S., Moore, S., Jiang, J. K., Raaka, B. M., Thomas, C. J., Krause, G., and Gershengorn, M. C. (2008) A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology 149, 5945-5950
23. Jaschke, H., Neumann, S., Moore, S., Thomas, C. J., Colson, A. O., Costanzi, S., Kleinau, G., Jiang, J. K., Paschke, R., Raaka, B. M., Krause, G., and Gershengorn, M. C. (2006) A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J. Biol. Chem. 281, 9841-9844 (Pubitemid 43864515)
24. Neumann, S., Huang, W., Titus, S., Krause, G., Kleinau, G., Alberobello, A. T., Zheng, W., Southall, N. T., Inglese, J., Austin, C. P., Celi, F. S., Gavrilova, O., Thomas, C. J., Raaka, B. M., and Gershengorn, M. C. (2009) Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Proc. Natl. Acad. Sci. U.S.A. 106, 12471-12476
25. Abe, E., Sun, L., Mechanick, J., Iqbal, J., Yamoah, K., Baliram, R., Arabi, A., Moonga, B. S., Davies, T. F., and Zaidi, M. (2007) Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Ann. N.Y. Acad. Sci. 1116, 383-391 (Pubitemid 350274344)
26. Frenzel, R., Voigt, C., and Paschke, R. (2006) The human thyrotropin receptor is predominantly internalized by beta-arrestin 2. Endocrinology 147, 3114-3122 (Pubitemid 43764647)
27. Laugwitz, K. L., Allgeier, A., Offermanns, S., Spicher, K., Van Sande, J., Dumont, J. E., and Schultz, G. (1996) The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc. Natl. Acad. Sci. U.S.A. 93, 116-120 (Pubitemid 26038113)
28. Buch, T. R., Biebermann, H., Kalwa, H., Pinkenburg, O., Hager, D., Barth, H., Aktories, K., Breit, A., and Gudermann, T. (2008) G13-dependent activation of MAPK by thyrotropin. J. Biol. Chem. 283, 20330-20341
29. De Gregorio, G., Coppa, A., Cosentino, C., Ucci, S., Messina, S., Nicolussi, A., D'Inzeo, S., Di Pardo, A., Avvedimento, E. V., and Porcellini, A. (2007) The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. Oncogene 26, 2039-2047 (Pubitemid 46514747)
30. Allen, M. D., Neumann, S., and Gershengorn, M. C. (2011) Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling. FASEB J. 25, 3687-3694
31. Urizar, E., Montanelli, L., Loy, T., Bonomi, M., Swillens, S., Gales, C., Bouvier, M., Smits, G., Vassart, G., and Costagliola, S. (2005) Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J. 24, 1954-1964 (Pubitemid 40896167)
32. Milligan, G. (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br. J. Pharmacol. 153(Suppl. 1), S216-S229
33. Vandeput, F., Perpete, S., Coulonval, K., Lamy, F., and Dumont, J. E. (2003) Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′-monophosphate and growth factors. Endocrinology 144, 1341-1349 (Pubitemid 36428476)
34. Neumann, S., Eliseeva, E., and Gershengorn, M. (2013) Beta-arrestin 1 mediates TSH receptor signaling. Paper presented at the 83rd Annual Meeting of the American Thyroid Association, A-45
35. Postiglione, M. P., Parlato, R., Rodriguez-Mallon, A., Rosica, A., Mithbaokar, P., Maresca, M., Marians, R. C., Davies, T. F., Zannini, M. S., De Felice, M., and Di Lauro, R. (2002) Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc. Natl. Acad. Sci. U.S.A. 99, 15462-15467 (Pubitemid 35407483)
36. Kumar, S., Nadeem, S., Stan, M. N., Coenen, M., and Bahn, R. S. (2011) A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J. Mol. Endocrinol. 46, 155-163